Why FDA Said No to a Melanoma Drug

• by Arthur Allen

• May 15, 2026

Consolidative use of radiotherapy to block oligoprogression in patients with metastatic melanoma on Systemic Therapy (CURB-Melanoma) - a single arm, phase 2 clinical trial

• by Oded Icht, Alexander Sun, Philip Wong, Andrew McPartlin, Thiago Pimentel Muniz, Anna Spreafico, Samuel D. Saibil, J. Nicholas Lukens, Sana D Karam, John De Almeida, Marcus O. Butler, C. Jillian Tsai

• July 6, 2026

Do Sitting Patterns Matter?

Researchers analyzed UK Biobank data to determine whether spending sedentary time in prolonged vs interrupted bouts was associated with subsequent cancer incidence and cancer mortality.

• by Kathryn Wighton

• July 16, 2026

• 4 min

Comparing the i31-SLNB and the MIA Nomogram for Sentinel Lymph Node Biopsy Positivity Prediction in Cutaneous Melanoma: A Prospective Cohort Analysis

• by Rohit Sharma, Rajan P. Kulkarni, Richard Essner, Andrew Ward, Andrew H. Lewis, Shireen Guide, J. Michael Guenther

• June 23, 2026